Cargando…

Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo

BACKGROUND: Gambiense human African trypanosomiasis (gHAT) has been brought under control recently with village-based active screening playing a major role in case reduction. In the approach to elimination, we investigate how to optimise active screening in villages in the Democratic Republic of Con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Christopher N., Rock, Kat S., Antillón, Marina, Miaka, Erick Mwamba, Keeling, Matt J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017623/ https://www.ncbi.nlm.nih.gov/pubmed/33794881 http://dx.doi.org/10.1186/s12916-021-01943-4

Ejemplares similares

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo
por: Aliee, Maryam, et al.
Publicado: (2021)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Modelling gambiense human African trypanosomiasis infection in villages of the Democratic Republic of Congo using Kolmogorov forward equations
por: Davis, Christopher N., et al.
Publicado: (2021)

Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo
por: Huang, Ching-I, et al.
Publicado: (2022)

Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2015)

Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo
por: Antillon, Marina, et al.
Publicado: (2022)

Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data
por: Davis, Christopher N, et al.
Publicado: (2021)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

The Flipside of Eradicating a Disease; Human African Trypanosomiasis in a Woman in Rural Democratic Republic of Congo: A Case Report
por: Mudji, Junior, et al.
Publicado: (2019)

A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC
por: Huang, Ching-I, et al.
Publicado: (2023)

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness
por: Castaño, M Soledad, et al.
Publicado: (2020)

Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo
por: Tirados, Inaki, et al.
Publicado: (2020)

Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2020)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003
por: Lutumba, Pascal, et al.
Publicado: (2005)

Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2017)

Prevalence of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Mumba, Dieudonne, et al.
Publicado: (2011)

Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2021)

Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo
por: Lumbala, Crispin, et al.
Publicado: (2017)

Human African Trypanosomiasis Transmission, Kinshasa, Democratic Republic of Congo
por: Simo, Gustave, et al.
Publicado: (2006)

An Active Follow-up Strategy for Serological Suspects of Human African Trypanosomiasis with Negative Parasitology Set up by a Health Zone Team in the Democratic Republic of Congo
por: Nkieri, Matthieu, et al.
Publicado: (2020)

Human African Trypanosomiasis in a Rural Community, Democratic Republic of Congo
por: Lutumba, Pascal, et al.
Publicado: (2007)

Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?
por: Hasker, Epco, et al.
Publicado: (2012)

Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk
por: Lumbala, Crispin, et al.
Publicado: (2015)

Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad
por: Rock, Kat S., et al.
Publicado: (2022)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Communities’ Perception, Knowledge, and Practices Related to Human African Trypanosomiasis in the Democratic Republic of Congo
por: Kabanga, Charlie, et al.
Publicado: (2022)

Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Inocencio da Luz, Raquel, et al.
Publicado: (2021)

Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad
por: Antillon, Marina, et al.
Publicado: (2023)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences
por: Falisse, Jean-Benoît, et al.
Publicado: (2020)

Trypanosomiasis Relapse after Melarsoprol Therapy, Democratic Republic of Congo, 1982–2001
por: Pépin, Jacques, et al.
Publicado: (2005)

Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC)
por: Castaño, María Soledad, et al.
Publicado: (2020)

Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo
por: Bessell, Paul R., et al.
Publicado: (2018)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis
por: Geerts, Manon, et al.
Publicado: (2020)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

Economic evaluation of disease elimination: An extension to the net-benefit framework and application to human African trypanosomiasis
por: Antillon, Marina, et al.
Publicado: (2021)

Accuracy of Five Algorithms to Diagnose Gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9gk9l90lvekuo4akble97k5ats